(Q44187507)

30 November 2017

Response to levodopa in parkinsonian patients with bilateral subthalamic nucleus stimulation (English)

1 reference

30 November 2017

1 reference

1 reference

1 reference

4

Pierre Pollak

1 reference

30 November 2017

1

Elena Moro

1 reference

30 November 2017

Rianne J A Esselink

2

1 reference

PubMed ID

12390968

30 November 2017

Alim Louis Benabid

series ordinal

3

1 reference

PubMed ID

12390968

30 November 2017

language of work or name

English

0 references

publication date

1 November 2002

1 reference

30 November 2017

1 reference

30 November 2017

125

1 reference

30 November 2017

Pt 11

1 reference

30 November 2017

2408-2417

1 reference

High-frequency stimulation produces a transient blockade of voltage-gated currents in subthalamic neurons

30 November 2017

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWF249

Impact of deep brain stimulation on upper limb akinesia in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWF249

Compensatory mechanisms in degenerative neurologic diseases. Insights from parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWF249

Striatal dopamine- and glutamate-mediated dysregulation in experimental parkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWF249

Deep-brain stimulation of the subthalamic nucleus or the pars interna of the globus pallidus in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWF249

Subthalamic nucleus stimulation improves directly levodopa induced dyskinesias in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWF249

Effect of subthalamic nucleus stimulation on levodopa-induced dyskinesia in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWF249

Utility of an objective dyskinesia rating scale for Parkinson's disease: inter- and intrarater reliability assessment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWF249

Comparison of motor response to apomorphine and levodopa in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWF249

Chronic stimulation of subthalamic nucleus improves levodopa-induced dyskinesias in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWF249

Subthalamic nucleus or internal pallidal stimulation in young onset Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWF249

Comparative effects of unilateral and bilateral subthalamic nucleus deep brain stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWF249

Core assessment program for intracerebral transplantations (CAPIT)

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWF249

Receptor basis for dopaminergic supersensitivity in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWF249

Electrical stimulation of the subthalamic nucleus in advanced Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWF249

Deep brain stimulation of the subthalamic nucleus: clinical effectiveness and safety.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWF249

Intravenous apomorphine therapy in Parkinson's disease: clinical and pharmacokinetic observations

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWF249

Levodopa-induced dyskinesias in Parkinson's disease phenomenology and pathophysiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWF249

Chronic subthalamic nucleus stimulation reduces medication requirements in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWF249

Pathogenesis of dyskinesias in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWF249

Modification of central dopaminergic mechanisms by continuous levodopa therapy for advanced Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWF249

Duodenal levodopa infusion in Parkinson's disease--long-term experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWF249

The response to levodopa in Parkinson's disease: imposing pharmacological law and order

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWF249

Interactions between deep brain stimulation and levodopa in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWF249

Levodopa motor complications in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWF249

Dopamine metabolism in the central nervous system after discontinuation of L-dopa therapy in patients with Parkinson disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWF249

Continuous dopamine-receptor stimulation in early Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWF249

An algorithm (decision tree) for the management of Parkinson's disease (2001): treatment guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWF249

Safety and efficacy of pallidal or subthalamic nucleus stimulation in advanced PD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWF249

21 January 2018

Identifiers

DOI

10.1093/BRAIN/AWF249

1 reference

30 November 2017

1 reference

PubMed ID

12390968